Mercury Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Mercury Laboratories has a total shareholder equity of ₹477.0M and total debt of ₹61.0M, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are ₹745.5M and ₹268.5M respectively. Mercury Laboratories's EBIT is ₹49.4M making its interest coverage ratio -111.1. It has cash and short-term investments of ₹59.1M.
Key information
12.8%
Debt to equity ratio
₹61.02m
Debt
Interest coverage ratio | -111.1x |
Cash | ₹59.13m |
Equity | ₹476.97m |
Total liabilities | ₹268.52m |
Total assets | ₹745.49m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 538964's short term assets (₹479.9M) exceed its short term liabilities (₹213.5M).
Long Term Liabilities: 538964's short term assets (₹479.9M) exceed its long term liabilities (₹55.1M).
Debt to Equity History and Analysis
Debt Level: 538964's net debt to equity ratio (0.4%) is considered satisfactory.
Reducing Debt: 538964's debt to equity ratio has reduced from 33.4% to 12.8% over the past 5 years.
Debt Coverage: 538964's debt is well covered by operating cash flow (40.5%).
Interest Coverage: 538964 earns more interest than it pays, so coverage of interest payments is not a concern.